3-arm Trial to Evaluate Pasireotide LAR/Everolimus Alone/in Combination in Patients With Lung/Thymus NET - LUNA Trial

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2013
This was a multicenter, randomized, phase II study evaluating Everolimus or Pasireotide LAR alone or in combination in adult patients with advanced (unresectable or metastatic) neuroendocrine carcinoma of the lung and thymus
Epistemonikos ID: 7f2d7716cb019d44e9cf5a35a52e6207c9d287e5
First added on: May 10, 2024